Revisor Wealth Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
4,244
+215
+5% +$44.7K 0.24% 104
2026
Q1
$842K Buy
4,029
+437
+12% +$94.1K 0.23% 115
2025
Q4
$734K Sell
3,592
-234
-6% -$44K 0.2% 119
2025
Q3
$601K Sell
3,826
-103
-3% -$15.9K 0.21% 104
2025
Q2
$636K Sell
3,929
-352
-8% -$52.2K 0.23% 95
2025
Q1
$590K Buy
4,281
+1,879
+78% +$240K 0.26% 78
2024
Q4
$286K Sell
2,402
-949
-28% -$111K 0.26% 78
2024
Q3
$370K Sell
3,351
-61
-2% -$6.38K 0.23% 103
2024
Q2
$336K Sell
3,412
-2,178
-39% -$222K 0.23% 98
2024
Q1
$595K Buy
5,590
+2,713
+94% +$293K 0.27% 97
2023
Q4
$290K Sell
2,877
-551
-16% -$54.7K 0.33% 76
2023
Q3
$298K Buy
3,428
+163
+5% +$14.7K 0.25% 106
2023
Q2
$309K Sell
3,265
-488
-13% -$41.2K 0.28% 101
2023
Q1
$283K Buy
+3,753
New +$283K 0.26% 109

Other funds holding CAH

Revisor Wealth Management's CAH Position: Q2 2026 in Review

Revisor Wealth Management increased its Cardinal Health (CAH) stake by 5.3% in Q2 2026, buying an estimated $44.7K and bringing the position to 4,244 shares worth $1.01M. The position accounts for 0.24% of the portfolio, ranked #104.

Revisor Wealth Management first reported a position in CAH in Q1 2023 and has held it in 14 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Revisor Wealth Management held 4,244 shares of Cardinal Health worth $1.01M as of Q2 2026.
  • Revisor Wealth Management bought 215 Cardinal Health shares in Q2 2026, an estimated $44.7K.
  • Cardinal Health made up 0.24% of Revisor Wealth Management's portfolio in Q2 2026, its #104 holding.
  • Revisor Wealth Management first reported a position in Cardinal Health in Q1 2023 and has held it in 14 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.